What this study is
This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.
What's being tested
- strategy of mailing buprenorphine
Intervention · OTHER
This study examines the feasibility and preliminary effectiveness of mailing buprenorphine to overcome barriers such as transportation to obtaining buprenorphine from a pharmacy.
Study details
- Official title
- A Pragmatic Remote Approach to Improve Transitions of Care and Retention in Opioid Use Disorder Treatment
- Sponsor
- Medical University of South Carolina
- Conditions
- Opioid Use Disorder
- Enrolling
- 20 people
- Starts
- 2026-04-08
- Est. completion
- 2027-03
- Design
- Open-label, single group, Early Phase 1
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age ≥ 18
- English-speaking
- Diagnosed with OUD and initiated on buprenorphine during hospitalization
- Discharging to a South Carolina address with a stable mailbox
- Access to phone or computer
You can't join if
- Active psychosis or suicidal ideation
- Severe medical or neurocognitive impairment
- Pending incarceration
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openContact for every open site
- Allison Smith, MD · Principal investigator
Medical University of South Carolina
Charleston, South Carolina, United States
- Allison Smith, MD · Contact843-792-2100smithall@musc.edu
Not yet recruitingMedical University of South Carolina
Charleston, South Carolina, United States
- Primary Investigator, MD · Contact843-792-0686smithall@musc.edu
- Research Coordinator, BS · Contactschneidh@musc.edu
Recruiting
Study team
Sponsor
Medical University of South Carolina
Study ID Pro00146867
Principal investigator
Allison Smith, MD
Medical University of South Carolina
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.